Back to Search Start Over

How to decide on the optimal duration of anticoagulatn therapy in carriers of the factor V Leiden mutation

Authors :
S, Middeldorp
H R, Büller
Source :
Thrombosis and haemostasis. 84(5)
Publication Year :
2000

Subjects

Subjects :
Heterozygote
Decision Making
Mutation
Anticoagulants
Factor V
Humans

Details

ISSN :
03406245
Volume :
84
Issue :
5
Database :
OpenAIRE
Journal :
Thrombosis and haemostasis
Accession number :
edsair.pmid..........bc0737181c3da0d7ffc4cfa15b799755

Tools

Authors Abstract Subjects Details